Mineralys Therapeutics Inc’s recent filing unveils that its Chief Medical Officer Rodman David Malcom unloaded Company’s shares for reported $0.41 million on Sep 15 ’25. In the deal valued at $36.00 per share,11,367 shares were sold. As a result of this transaction, Rodman David Malcom now holds 81,524 shares worth roughly $3.16 million.
Then, Rodman David Malcom bought 11,367 shares, generating $409,266 in total proceeds.
Before that, AKKARAJU SRINIVAS bought 588,235 shares. Mineralys Therapeutics Inc shares valued at $14,999,992 were divested by the Director at a price of $25.50 per share. As a result of the transaction, AKKARAJU SRINIVAS now holds 588,235 shares, worth roughly $22.81 million.
Jefferies initiated its Mineralys Therapeutics Inc [MLYS] rating to a Hold in a research note published on June 11, 2025; the price target was $15. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Goldman began covering MLYS with “Buy” recommendation on April 02, 2024. Wells Fargo started covering the stock on March 07, 2023. It rated MLYS as “an Overweight”.
Price Performance Review of MLYS
On Monday, Mineralys Therapeutics Inc [NASDAQ:MLYS] saw its stock fall -1.25% to $38.78. Over the last five days, the stock has gained 7.10%. Mineralys Therapeutics Inc shares have risen nearly 231.74% since the year began. Nevertheless, the stocks have risen 215.03% over the past one year. While a 52-week high of $40.33 was reached on 09/18/25, a 52-week low of $8.24 was recorded on 02/25/25.
Levels Of Support And Resistance For MLYS Stock
The 24-hour chart illustrates a support level at 38.03, which if violated will result in even more drops to 37.27. On the upside, there is a resistance level at 39.53. A further resistance level may holdings at 40.28.
How much short interest is there in Mineralys Therapeutics Inc?
A steep rise in short interest was recorded in Mineralys Therapeutics Inc stocks on 2025-08-29, growing by 0.62 million shares to a total of 7.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 7.0 million shares. There was a rise of 8.14%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 07, 2023 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $45 price target.
